Seiichi Yoshida1. 1. Department of Neurosurgery, Niigata Cancer Center Hospital, Niigata 951-8566, Japan. brain@niigata-cc.jp
Abstract
BACKGROUND: Brain metastasis from esophageal carcinoma is rare, and its natural history is unclear. To determine predictors for their outcomes, we conducted a retrospective review of patients. METHODS: We treated 803 patients with metastatic brain tumors, and there were 17 patients with brain metastases from esophageal carcinoma. Their median age at the diagnosis was 57 years. RESULTS: In the 15 patients with the pretreatment KPS of 70 or higher, the median survival after the diagnosis of brain metastasis was 26.2 months. Seven patients showed the median survival of 17.7 months after resection alone. The median survival was 65.5 months in the 3 patients who were treated with resection plus radiation. CONCLUSIONS: Neurosurgical resection followed by WBRT seemed to be the indicated treatment in these patients.
BACKGROUND:Brain metastasis from esophageal carcinoma is rare, and its natural history is unclear. To determine predictors for their outcomes, we conducted a retrospective review of patients. METHODS: We treated 803 patients with metastatic brain tumors, and there were 17 patients with brain metastases from esophageal carcinoma. Their median age at the diagnosis was 57 years. RESULTS: In the 15 patients with the pretreatment KPS of 70 or higher, the median survival after the diagnosis of brain metastasis was 26.2 months. Seven patients showed the median survival of 17.7 months after resection alone. The median survival was 65.5 months in the 3 patients who were treated with resection plus radiation. CONCLUSIONS: Neurosurgical resection followed by WBRT seemed to be the indicated treatment in these patients.
Authors: Taher Abu Hejleh; Barry R Deyoung; Eric Engelman; Jeremy M Deutsch; Bridget Zimmerman; Thorvardur R Halfdanarson; Daniel J Berg; Kalpaj R Parekh; William R Lynch; Mark D Iannettoni; Sudershan Bhatia; Gerald Clamon Journal: World J Gastrointest Oncol Date: 2012-05-15
Authors: Matthias J Krammer; Andre Tomasino; David B Schul; Sabrina T Astner; Michael P Meier; Christianto B Lumenta Journal: J Neurooncol Date: 2011-06-21 Impact factor: 4.130
Authors: Nishi Kothari; Eric Mellon; Sarah E Hoffe; Jessica Frakes; Ravi Shridhar; Jose Pimiento; Ken Meredith; Nam D Tran; Nadia Saeed; Khaldoun Almhanna Journal: J Gastrointest Oncol Date: 2016-08
Authors: Greg Bowden; Hideyuki Kano; Zachary J Tempel; Ellen Caparosa; Edward Monaco; Ajay Niranjan; John Flickinger; James D Luketich; L Dade Lunsford Journal: J Neurooncol Date: 2014-04-16 Impact factor: 4.130